InvestorsHub Logo
Followers 24
Posts 3808
Boards Moderated 0
Alias Born 02/04/2013

Re: itsabouttime post# 214567

Monday, 04/06/2015 11:47:29 PM

Monday, April 06, 2015 11:47:29 PM

Post# of 346073
Mary J. Boyd was hired in July 2007, which was almost 8 years ago. Per the Peregrine News Release, they stated the following:

..today announced the appointment of Mary J. Boyd, Ph.D. as head of business development for Asia and Europe. Dr. Boyd has more than 20 years of international pharmaceutical and biotechnology business development experience with large pharmaceutical companies including GlaxoSmithKline, Novartis and Roche. She will focus on identifying potential partners and negotiating agreements for Peregrine's extensive clinical and preclinical assets in Asian and European markets.

So how many Partnerships has Peregrine had since here hiring? The STASON Partnership which as everyone knows brought a ton of value for the Shareholders.

So you think that over the next 8 years, Mary Boyd will continue to be super busy and FOCUSED on Identifying those Partners? Maybe she will find one who will actually sign on the dotted line.

$25 Billion is Bread Crumbs because PPHM has the "Golden Goose"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News